Acadia Pharmaceuticals · Health Care
ACAD
$25.60
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.阿卡迪亚制药公司（AcadiaPharmaceuticalsInc.）是一家生物制药公司，总部位于加利福尼亚州德尔马。
Mixed profile混合特征
Mid cap中盘
$4B
Engine stance引擎立场2026-07-20
Lagging — relative weakness落后 — 相对弱势
The bottoming setup is not yet confirmed (price still below the 10-day average) and oscillators are already extended/ove筑底形态尚未确认（价格仍位于 10 日均线下方），且摆动指标已过热——此处入场风险较高。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$25.60
8.8% below 52-week high低于52周高点 8.8%
Market Cap市值
$4B
Normal volume正常成交量
P/E Ratio市盈率
11.2x
28.9x sector median
Beta贝塔
0.95
Moves about 1.0x the market波动幅度约为市场的 1.0 倍
RSI (14)RSI（14）
63
Elevated偏高
Next Earnings下次财报
2026-08-05 (17d)
Volatility Rank波动率分位
34th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
6.4% of float
Performance价格表现
| Period周期 | ACAD | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -2.4% | -1.5% | In line with the index与指数基本持平 |
| 1 Month近1月 | +18.5% | +0.6% | Beat the index by 17.9 points跑赢指数 17.9 个百分点 |
| 3 Months近3月 | +15.5% | +4.7% | Beat the index by 10.8 points跑赢指数 10.8 个百分点 |
| 6 Months近6月 | -1.5% | +7.8% | Lagged the index by 9.3 points落后指数 9.3 个百分点 |
| Year to date年初至今 | -2.6% | +9.1% | Lagged the index by 11.7 points落后指数 11.7 个百分点 |
| 1 Year近1年 | +13.5% | +19.4% | Lagged the index by 5.9 points落后指数 5.9 个百分点 |
| 3 Years近3年 | -22.4% | +69.4% | Lagged the index by 91.8 points落后指数 91.8 个百分点 |
Technicals技术面
RSI (14)RSI（14）
63
Elevated偏高
vs 50-day相对50日均线
+12.0% vs 50-day avg
vs 200-day相对200日均线
+9.3% vs 200-day avg
Volatility rank波动率分位
34th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$24.96
Don't chase above不追高于
$25.60
Stop止损
$20.94
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
17
days until next report天后公布财报
2026-08-05
Estimates being cut预期下调
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | ACAD | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 11.15x | 28.92 | 95% |
| P/B市净率 | 3.55x | 3.52 | 49% |
| P/S市销率 | 4.07x | 3.02 | 37% |
| Earnings yield盈利收益率 | 8.97% | 2.72 | 97% |
| FCF yield自由现金流收益率 | 2.41% | 3.94 | 28% |
| EV/EBITDA企业价值/EBITDA | 39.57x | 18.21 | 14% |
| P/FCF市值/自由现金流 | 41.47x | 22.42 | 17% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 19.4%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
31.9%Return on Equity股本回报率
25.0%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -1.68 |
| Current ratio流动比率 | 3.83 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $52.1M |
| Share count change (1y)股数变化（1年） | +2.2% |
Piotroski皮奥特罗斯基 5/8
Altman Z阿尔特曼Z: safe (7.7)
Warning警示
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 45% of its sector on blended multiples综合估值倍数低于行业内 45% 的公司
Beta市场敏感度
0.95×
0.21×3×
Moves about 1.0× the market波动幅度约为市场的 1.0 倍
Financial Health财务健康
5/8
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
ACAD daily MACD crossed downACAD 日线MACD下穿
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$1.8M net (0 buyers, 6 sellers)-$1.8M 净值（0 买家，6 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Baker Bros. Advisors | A | Holding持有 | 5.5% | 2026-03-31 |
| RTW Investments | B | Holding持有 | 1.6% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 16, 2026
ACAD daily MACD crossed downACAD 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $25.63.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$25.63。
Jul 15, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 15, 2026
ACAD took relative-strength leadershipACAD 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $25.92.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$25.92。
Jul 13, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Jul 7, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Jul 6, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Jul 2, 2026
ACAD took relative-strength leadershipACAD 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $25.97.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$25.97。
Jul 1, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Showing last 15 of显示最近15条，共 247 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -1.07
Value价值
-0.2
Quality质量
-2.8
Investment资本投入
-1.4
Low volatility低波动
+0.1
Low market beta低市场敏感度
-0.1
Earnings quality盈利质量
-3.0
Short interest空头兴趣
-0.3
Company Profile公司档案
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.阿卡迪亚制药公司（AcadiaPharmaceuticalsInc.）是一家生物制药公司，总部位于加利福尼亚州德尔马。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Receivables stretch
- Capital intensity rising
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。